RenaissanceRe (RNR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Achieved strong Q1 2026 results with $591M operating income, $284.5M net income, 22% annualized operating ROE, and $13.75 operating EPS, supported by robust underwriting, fee, and investment income.
Combined ratio improved to 73.0% from 128.3% year-over-year, reflecting disciplined underwriting and portfolio management.
Tangible book value per share increased 1.5% to $233.49, with book value per share up 1.4% to $250.48.
Repurchased $353M in shares in Q1 2026, with an additional $104.8M in April, totaling $457.3M.
Limited exposure to Middle East war and fully reserved specialty line losses.
Financial highlights
Underwriting income of $589M, with gross premiums written at $3.4B (down 16% YoY), and net premiums earned at $2.18B (down 20%).
Fee income totaled $94M, with strong management and performance fee contributions.
Net investment income rose to $420.5M, up 3.7% year-over-year, despite $421.9M in net realized and unrealized investment losses.
Book value per common share plus accumulated dividends rose to $280.57.
Retained mark-to-market losses of $350M, mainly from fixed maturity and equity portfolios.
Outlook and guidance
Management remains focused on disciplined underwriting, margin over growth, and shaping the portfolio for superior returns, especially in property catastrophe.
Investment portfolio repositioned for attractive interest rates, with increased allocation to investment-grade credit and extended duration.
Q2 guidance: other property net premiums earned ~$350M, attritional loss ratio mid-50s; casualty/specialty net premiums ~$1.3B, adjusted combined ratio high 90s.
Management fees expected ~$50M in Q2; performance fees ~$120M for the year, barring large losses.
Ongoing investment in technology and risk modeling, including climate change impacts.
Latest events from RenaissanceRe
- Strong growth, diversification, and profitability driven by acquisitions and risk-focused strategy.RNR
Investor presentation17 Apr 2026 - Approval of a new long-term incentive plan is sought to support growth and align interests.RNR
Proxy filing10 Apr 2026 - Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025